Small Molecules
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
172
NCT02064725
Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA
Phase: Phase 2
Role: Collaborator
Start: Sep 30, 2014
Completion: Jul 31, 2018
NCT03640559
Safety and Tolerability of Seroguard Use
Phase: Phase 1
Role: Lead Sponsor
Start: May 19, 2015
Completion: Oct 4, 2015
NCT03660787
Efficacy and Dose Ranging Study of Seroguard
Start: May 4, 2017
Completion: Jan 23, 2018
Loading map...